ストックスクリーナーアプリを入手
25.87
2.08%
-0.55
アフターアワーズ：
25.80
-0.07
-0.27%
Amphastar Pharmaceuticals Inc (AMPH) 最新ニュース
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock? - Zacks Investment Research
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock? - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Rating Raised to Strong-Buy at Wall Street Zen - MarketBeat
AMPH5896384 Bond Profile: Coupon and Redemption - tradingview.com
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Forecasts - Yahoo! Finance Canada
A Look at Amphastar Pharmaceuticals Inc (AMPH) After 3.3% Decline -- GF Value $36.36 vs Price $25.81 - GuruFocus
Amphastar: 2 Years Since My Last Hold Call, I Remain On Sidelines (NASDAQ:AMPH) - Seeking Alpha
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Rating of "Reduce" from Analysts - MarketBeat
Bank of America Corp DE Makes New Investment in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Up 5.7%What's Next? - MarketBeat
Is It Too Late to Buy Amphastar Pharmaceuticals Inc (AMPH) After 5.2% Rally? GF Value Says Undervalued - GuruFocus
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Forecasts - Yahoo Finance
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Forecasts - Yahoo! Finance Canada
Insider Selling: Amphastar Pharmaceuticals (NASDAQ:AMPH) CFO Sells 4,139 Shares - MarketBeat
At $25 a share, Amphastar Pharmaceuticals (AMPH) CFO William Peters sold 4,139 shares. - Stock Titan
Amphastar (NASDAQ: AMPH) exec plans 4,139-share Rule 144 sale - Stock Titan
Amphastar Pharmaceuticals (NASDAQ:AMPH): Strongest Q2 Results from the Generic Pharmaceuticals Group - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat
Legal & General Group Plc Makes New $1.58 Million Investment in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals (AMPH) Rebounds In Focus, Is It Slightly Overvalued? - Yahoo Finance
Bank of New York Mellon Corp Makes New Investment in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat
Amphastar Pharmaceuticals (AMPH) Stock Looks Cheap With Earnings Doing The Heavy Lifting - Yahoo Finance
Rong Zhou Sells 3,187 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock - MarketBeat
Insider sells 3,187 shares at Amphastar (NASDAQ: AMPH) - Stock Titan
A Look at Amphastar Pharmaceuticals Inc (AMPH) After 3.3% Gain -- GF Value $35.96 vs Price $23.74 - GuruFocus
Empowered Funds LLC Invests $3.29 Million in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar (NASDAQ: AMPH) VP plans Rule 144 stock sale led by 10,000-share option exercise - Stock Titan
Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference - Stock Titan
Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference - PR Newswire
Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Sandoz and Viatris - Yahoo Finance
Bank of America Corp DE Acquires 46,149 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals, Inc. $AMPH Stock Holdings Lifted by Algert Global LLC - marketbeat.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Passes Above 50-Day Moving AverageShould You Sell? - marketbeat.com
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for - Eastern Progress
Amphastar Pharmaceuticals Earnings Call Balances Growth And Risk - TipRanks
Denali Advisors LLC Has $7.59 Million Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar (AMPH) Quarterly Results: EPS Exceeds Its Estimate in Latest Trading; Trading Response: The Stock Ends Up 2.30% on the DayEarnings Weakness Phase - Vinanet
Amphastar (NASDAQ: AMPH) insider lines up stock sale after option exercise - Stock Titan
Barclays Issues Positive Forecast for Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price - MarketBeat
Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating - marketscreener.com
Is It Too Late to Buy Amphastar Pharmaceuticals Inc (AMPH) After 3.6% Rally? GF Value Says Undervalued - GuruFocus
Lead Independent Director Richard Prins Sold A Bunch Of Shares In Amphastar Pharmaceuticals - simplywall.st
Lead Independent Director Richard Prins Sold A Bunch Of Shares In Amphastar Pharmaceuticals - webull.com
The Top 5 Analyst Questions From Amphastar Pharmaceuticals’s Q2 Earnings Call - Yahoo Finance
Amphastar Pharmaceuticals (AMPH) Director Richard Prins Sells 7, - GuruFocus
Richard Prins Sells 7,973 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock - MarketBeat
Amphastar director Richard Prins disposes of shares valued at $161,851 By Investing.com - Investing.com South Africa
Amphastar director Richard Prins disposes of shares valued at $161,851 - Investing.com
Amphastar director Richard Prins disposes of shares valued at $161,851 - Investing.com
5.11%
0.31%
大文字化:
|
ボリューム (24 時間):